dioxanes - CISMeF

Preferred Label : dioxanes;

MeSH definition : 1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), dioxane itself may reasonably be anticipated to be a carcinogen. (Merck Index, 11th ed); Compounds that contain the structure 1,4-dioxane.;

Wikipedia automatic translation : 1,4-Dioxane;

MeSH annotation : indust solvents;

Wikipedia link : https://en.wikipedia.org/wiki/1,4-Dioxane;

Is substance : O;

Détails

Origin ID

D004146;

UMLS CUI

C0012501;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 1,4-Dioxane [NCIt concept]
Record concept(s)
- dioxanes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1-(2-fluoroethyl)piperidin-4-yl)methyl 8-amino-7-chloro-2,3-dihydrobenzo(b)(1,4)dioxine-5-carboxylate [MeSH Supplementary Concept]
- (2,3-dihydrobenzo(b)(1,4)dioxin-2-yl)(5-(3-fluorophenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)methanone [MeSH Supplementary Concept]
- (2-(2',3'-dihydrobenzo(1,4)dioxin-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethylethyl)nonanoic acid amide [MeSH Supplementary Concept]
- (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane [MeSH Supplementary Concept]
- (3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine monohydrochloride [MeSH Supplementary Concept]
- (6,6-diphenyl-1,4-dioxan-2-yl)-N,N-dimethylmethanamine [MeSH Supplementary Concept]
- 1,2-O-isopropylidene-pentodialdo-1,4-furanose [MeSH Supplementary Concept]
- 1,4-benzodioxan [MeSH Supplementary Concept]
- 1,4-benzodioxane [MeSH Supplementary Concept]
- 1,4-dioxane [MeSH Supplementary Concept]
- 1-(1-(2,3-dihydrobenzo(1,4)dioxin-2-yl)methyl)-4-(3-methoxymethylpyridin-2-yl)piperazine [MeSH Supplementary Concept]
- 1-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-4-((6-fluoropyridin-3-yl)methyl)piperazine [MeSH Supplementary Concept]
- 1-(2-(1-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl)piperidin-4-yl)ethyl)-3-(2,4,6-trimethoxyphenyl)imidazolidin-2-one [MeSH Supplementary Concept]
- 1-(2-(4-((2,3-dihydro(1,4)dioxino(2,3-c)pyridin-7-ylmethyl)amino)-3-fluoropiperidin-1-yl)ethyl)-2-oxo-1,2-dihydroquinoline-7-carbonitrile [MeSH Supplementary Concept]
- 1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin [MeSH Supplementary Concept]
- 1-(3',5'-dihydroxyphenoxy)-7-(2',4',6-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4-dioxin [MeSH Supplementary Concept]
- 10-carboxy-11,12,13,14-tetranor-plakortide Q [MeSH Supplementary Concept]
- 11,12-didehydro-13-oxo-plakortide Q [MeSH Supplementary Concept]
- 2,2-dimethyl-1,3-dioxan-5-one [MeSH Supplementary Concept]
- 2,2-dimethyl-5-nitroso-1,3-dioxan-5-yl 4-chlorobenzoate [MeSH Supplementary Concept]
- 2,2-dimethyl-5-nitroso-1,3-dioxan-5-yl benzoate [MeSH Supplementary Concept]
- 2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)(1-((2-(4-fluorophenyl)-oxazol-4-yl)methyl)piperidin-4-yl)methanone [MeSH Supplementary Concept]
- 2,4,6-triphenyl-1,3-dioxane [MeSH Supplementary Concept]
- 2,5-dioxo-3-tetratriacont-3'-enyl-1,4-dioxane [MeSH Supplementary Concept]
- 2,6-dimethyl-1,3-dioxane-4-ol [MeSH Supplementary Concept]
- 2,7''-phloroglucinol-6,6'-bieckol [MeSH Supplementary Concept]
- 2-((2-(2,6-dimethoxyphenoxy)ethyl)amino)methyl-1,4-dioxane(1,2-b)naphthalene [MeSH Supplementary Concept]
- 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-(1,4)dioxino(2',3'-3,4)benzo(1,2-d)imidazole-5-carboxamide [MeSH Supplementary Concept]
- 2-((2-ethyl(2,6-dimethoxyphenoxy)amino)methyl)1,4-dioxane-(2,3-b)naphthalene [MeSH Supplementary Concept]
- 2-((5-methyl-1,4-dioxan-2-yl)methoxy)ethanol [MeSH Supplementary Concept]
- 2-((N-(aminocarbonyl)-N-hydroxyamino)methyl)-1,4-benzodioxan [MeSH Supplementary Concept]
- 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane [MeSH Supplementary Concept]
- 2-(1,4-benzodioxan-6-yl)-4,5-dihydroimidazole [MeSH Supplementary Concept]
- 2-(2,3-dihydro-1H-inden-2-yl)-N-(1-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)acetamide [MeSH Supplementary Concept]
- 2-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-6-methylimidazo(1,2-a)pyridine [MeSH Supplementary Concept]
- 2-(2-ethyl-2-phenyl-1,3-dioxan-4-yl)ethan-1-amine [MeSH Supplementary Concept]
- 2-(2-pyrrolidinyl)benzodioxane [MeSH Supplementary Concept]
- 2-(4-(4-fluorophenyl)-5-(2-(3-cyclopropylmethyl)pyrimidin-4-yl)-1H-imidazol-2-yl)-5-methyl-(1,3)dioxane-5-carboxylic acid 4-methylpiperazinamide [MeSH Supplementary Concept]
- 2-(5-fluorouracil-1-yl)-5-hydroxymethyl-3-(uracil-1-yl)-1,4-dioxane [MeSH Supplementary Concept]
- 2-(benzyl(2-((4-carbamimidoylphenoxy)methyl)-2,3-dihydro-1,4-benzodioxin-6-yl)amino)-2-oxoacetic acid [MeSH Supplementary Concept]
- 2-aminomethyl-1,4-benzodioxane [MeSH Supplementary Concept]
- 2-ethyl-5,5-dimethyl-1,3-dioxane [MeSH Supplementary Concept]
- 2-methyl-2-phenyl-1,3-dioxane-4,6-dione-keto-dioxinone [MeSH Supplementary Concept]
- 2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid [MeSH Supplementary Concept]
- 2-methyl-c-5-(4-(5-methyl-2-phenyl-1,3-oxazol-4-yl)butyl)-1,3-dioxane-r-2-carboxylic acid [MeSH Supplementary Concept]
- 3,4,3',4'-tetra-O-acetyl-6,6'-bis(triphenylmethyl)-difructose anhydride I [MeSH Supplementary Concept]
- 3-(((2,6-difluorophenyl)amino)methyl)-5-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-1,3,4-oxadiazole-2(3H)-thione [MeSH Supplementary Concept]
- 3-((-(2,6-dimethoxyphenoxy)ethyl)amino)methyl-1,4-dioxane(1,2-b)naphthalene [MeSH Supplementary Concept]
- 3-deoxysilybin [MeSH Supplementary Concept]
- 3-methylene-6-methyl-1,4-dioxane-2,5-dione [MeSH Supplementary Concept]
- 4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane [MeSH Supplementary Concept]
- 4,4-dimethyl-1,3-dioxane [MeSH Supplementary Concept]
- 4,6-diethyl-6-(4-ethyl-5-octenyl)-1,2-dioxane-3-acetic acid [MeSH Supplementary Concept]
- 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-((5-nitro-2-thiazolyl)thio)-3H-1,2,4-triazol-3-one [MeSH Supplementary Concept]
- 4-(2-(3-(4-hydroxy-3,5-dimethoxyphenyl)-2-hydroxymethyl-8-methoxy-2,3-dihydrobenzo(1,4)dioxin-6-yl)ethyl)-1-methoxybenzene [MeSH Supplementary Concept]
- 4-cyano-4-(2,3-dihydro-8-methoxy-1,4-benzodioxin-5-yl)cyclohexanecarboxylic acid [MeSH Supplementary Concept]
- 4-dioxanone [MeSH Supplementary Concept]
- 4-ethoxy-1,4-dihydro-2,3-benzodioxin-1-ol [MeSH Supplementary Concept]
- 4-methyl-4-hydroxyethyl-1,3-dioxane [MeSH Supplementary Concept]
- 4-methyl-4-phenyl-1,3-dioxane [MeSH Supplementary Concept]
- 4-oxymethyl-1,2-dioxane [MeSH Supplementary Concept]
- 4-phenyl-1,3-dioxane [MeSH Supplementary Concept]
- 5,5-dimethyl-2-(5-nitrofuran-2-yl)-4-phenyl-1,3-dioxane [MeSH Supplementary Concept]
- 5,5-ditetradecyl-2-(2-trimethylammonioethyl)-1,3-dioxane bromide [MeSH Supplementary Concept]
- 5,8-divinyl-1,4-dihydro-1,4-di-O-beta-D-glucopyranosyl-2,3-dioxane [MeSH Supplementary Concept]
- 5-(((3-fluorophenyl)amino)methylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione [MeSH Supplementary Concept]
- 5-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-3-(((3,4,5-trifluorophenyl)amino)methyl)-1,3,4-oxadiazole-2(3H)-thione [MeSH Supplementary Concept]
- 5-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-3-((4-(3(trifluoromethyl)phenyl)piperazin-1-yl)methyl)-1,3,4-oxadiazole-2(3H)-thione [MeSH Supplementary Concept]
- 5-(6-(4-methanesulfonyloxyphenyl)hexyl)-2-methyl-1,3-dioxane-2-carboxylic acid [MeSH Supplementary Concept]
- 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-(2-phenylethyl)-4-piperidinyl)-1,3,4-oxadiazol-2(3H)-one [MeSH Supplementary Concept]
- 5-(methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione [MeSH Supplementary Concept]
- 5-amino-2,2-dimethyl-4-phenyl-1,3-dioxane [MeSH Supplementary Concept]
- 5-bromo-5-nitro-1,3-dioxane [MeSH Supplementary Concept]
- 5-chloro-2-phenyldioxane [MeSH Supplementary Concept]
- 5-methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one [MeSH Supplementary Concept]
- 5-nitroso-1,3-dioxan-5-yl 4-chlorobenzoate [MeSH Supplementary Concept]
- 6,7-benzoidazoxan [MeSH Supplementary Concept]
- 6-(4-benzylpiperazin-1-yl)benzodioxane [MeSH Supplementary Concept]
- 6-nitro-1,3-benzodioxane [MeSH Supplementary Concept]
- 7,8-dihydroplakortide E [MeSH Supplementary Concept]
- 7-(2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)heptenoic acid [MeSH Supplementary Concept]
- 7-(2-(2-aza-2-(((phenylamino)thioxomethyl)amino)vinyl)-4-methyl-3,5-dioxanyl)hept-5-enoic acid [MeSH Supplementary Concept]
- 7-(4-((4-(5-(5-carboxypent-2-enyl)-4-(2-hydroxyphenyl)-1,3-dioxan-2-yl)benzyl)oxy)phenyl)-7-(3-pyridyl)hept-6-enoic acid [MeSH Supplementary Concept]
- 7-aminoidazoxan [MeSH Supplementary Concept]
- A175 compound [MeSH Supplementary Concept]
- ACC 7513 [MeSH Supplementary Concept]
- BTS 79018 [MeSH Supplementary Concept]
- BYI 06830 [MeSH Supplementary Concept]
- E 4701 [MeSH Supplementary Concept]
- F 1394 [MeSH Supplementary Concept]
- FMC 25213 [MeSH Supplementary Concept]
- GYKI 12743 [MeSH Supplementary Concept]
- ICI 180080 [MeSH Supplementary Concept]
- ICI 185282 [MeSH Supplementary Concept]
- ICI 192605 [MeSH Supplementary Concept]
- ICI D1542 [MeSH Supplementary Concept]
- JNJ 10397049 [MeSH Supplementary Concept]
- KS 5-2 [MeSH Supplementary Concept]
- KW 4490 [MeSH Supplementary Concept]
- Lisaftoclax [MeSH Supplementary Concept]
- MDL 75608A [MeSH Supplementary Concept]
- MS 1-2 [MeSH Supplementary Concept]
- N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide [MeSH Supplementary Concept]
- N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-(methoxymethoxy)phenoxy)ethanamine [MeSH Supplementary Concept]
- N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine [MeSH Supplementary Concept]
- N-((6-chloro-2,3-dihydrobenzo(1,4)dioxin-2-yl)methyl)sulfamide [MeSH Supplementary Concept]
- N-(2-(2-(1,3-dioxan-2-yl)phenoxy)-ethyl)phthalimide [MeSH Supplementary Concept]
- N-(3-methoxypropyl)-1,4-benzodioxan-2-methylamine [MeSH Supplementary Concept]
- N-benzyl-2-(2-phenyl-1,3-dioxan-4-yl)ethan-1-amine [MeSH Supplementary Concept]
- N-hydroxyguanoxan [MeSH Supplementary Concept]
- NED-180 [MeSH Supplementary Concept]
- ONO-RS 347 [MeSH Supplementary Concept]
- PAK inhibitor MRIA9 [MeSH Supplementary Concept]
- PX 916 [MeSH Supplementary Concept]
- R 102557 [MeSH Supplementary Concept]
- R 28935 [MeSH Supplementary Concept]
- RG 13647 [MeSH Supplementary Concept]
- S 14489 [MeSH Supplementary Concept]
- S 15931 [MeSH Supplementary Concept]
- SB 204070A [MeSH Supplementary Concept]
- SB 205008 [MeSH Supplementary Concept]
- SB 207710 [MeSH Supplementary Concept]
- SMP-304 [MeSH Supplementary Concept]
- SR-0065 [MeSH Supplementary Concept]
- VUFB 17951 [MeSH Supplementary Concept]
- VUFB 17959 [MeSH Supplementary Concept]
- WB 4371 [MeSH Supplementary Concept]
- WB-4123 [MeSH Supplementary Concept]
- Y 3506 [MeSH Supplementary Concept]
- ambenoxan [MeSH Supplementary Concept]
- americanin B [MeSH Supplementary Concept]
- americanol A [MeSH Supplementary Concept]
- artabotrycinol [MeSH Supplementary Concept]
- axinylsterol [MeSH Supplementary Concept]
- beditine [MeSH Supplementary Concept]
- biosyn terpolymer [MeSH Supplementary Concept]
- butamoxan [MeSH Supplementary Concept]
- butyroxan [MeSH Supplementary Concept]
- citriodolic acid A [MeSH Supplementary Concept]
- citriodolic acid B [MeSH Supplementary Concept]
- citriodolic acid C [MeSH Supplementary Concept]
- clazosentan [MeSH Supplementary Concept]
- clinopodic acid C [MeSH Supplementary Concept]
- coruscol A [MeSH Supplementary Concept]
- dilactide [MeSH Supplementary Concept]
- dimethoxane [MeSH Supplementary Concept]
- dimethyldioxane [MeSH Supplementary Concept]
- eckstolonol [MeSH Supplementary Concept]
- ethomoxane [MeSH Supplementary Concept]
- ethyl 1,4-benzodioxane-2-carboxylate [MeSH Supplementary Concept]
- ethyl 2-(2-(2-(2,3-dihydro-1,4-benzodioxin-7-ylamino)-2-oxoethyl)-1-oxoisoquinolin-5-yl)oxypropanoate [MeSH Supplementary Concept]
- ethyl 5-methyl-4-(2,5,5-trimethyl-1,3-dioxan-2-yl)isoxazole-3-carboxylate [MeSH Supplementary Concept]
- glycolide E-caprolactone copolymer [MeSH Supplementary Concept]
- glycomer 631 [MeSH Supplementary Concept]
- guaimesal [MeSH Supplementary Concept]
- haterumadioxin A [MeSH Supplementary Concept]
- haterumadioxin B [MeSH Supplementary Concept]
- isoamericanol A [MeSH Supplementary Concept]
- lecozotan [MeSH Supplementary Concept]
- lennoxamine [MeSH Supplementary Concept]
- magallanesine [MeSH Supplementary Concept]
- meldrum's acid [MeSH Supplementary Concept]
- mesedin [MeSH Supplementary Concept]
- methyl capucinoate A [MeSH Supplementary Concept]
- monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) [MeSH Supplementary Concept]
- nibroxane [MeSH Supplementary Concept]
- nicoyamycin A [MeSH Supplementary Concept]
- nuevamine [MeSH Supplementary Concept]
- ocobullenone [MeSH Supplementary Concept]
- osemozotan [MeSH Supplementary Concept]
- oxysporone [MeSH Supplementary Concept]
- palmarumycin CP(1) [MeSH Supplementary Concept]
- paraldol [MeSH Supplementary Concept]
- peroxyacarnoate A [MeSH Supplementary Concept]
- peroxyacarnoate D [MeSH Supplementary Concept]
- peroxyacarnoic acid methyl ester A [MeSH Supplementary Concept]
- peroxyacarnoic acid methyl ester B [MeSH Supplementary Concept]
- phendioxan [MeSH Supplementary Concept]
- phyllostin [MeSH Supplementary Concept]
- plakoric acid [MeSH Supplementary Concept]
- plakortide E [MeSH Supplementary Concept]
- plakortide F [MeSH Supplementary Concept]
- plakortide G [MeSH Supplementary Concept]
- plakortide H [MeSH Supplementary Concept]
- plakortide M [MeSH Supplementary Concept]
- plakortide N [MeSH Supplementary Concept]
- plakortolide E [MeSH Supplementary Concept]
- poly(ethylene oxide)-b-poly(D,L-lactide) [MeSH Supplementary Concept]
- poly(vanillin oxalate) [MeSH Supplementary Concept]
- poly-4-dioxan-2-one [MeSH Supplementary Concept]
- polydioxane sulfate [MeSH Supplementary Concept]
- polytrimethylene carbonate [MeSH Supplementary Concept]
- proroxan [MeSH Supplementary Concept]
- prosympal [MeSH Supplementary Concept]
- spiro(6-methyl-1,4-dioxane-2,5-dione-3,2'-bicyclo(2.2.1)hept(5)ene) [MeSH Supplementary Concept]
- spiroxatrine [MeSH Supplementary Concept]
- strobilurin N [MeSH Supplementary Concept]
- tin(II) dioxinate [MeSH Supplementary Concept]
- trimethylene carbonate [MeSH Supplementary Concept]
- uretupamine A [MeSH Supplementary Concept]
- uretupamine B [MeSH Supplementary Concept]
- zeylenone [MeSH Supplementary Concept]
Semantic type(s)
- Hazardous or Poisonous Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- 1,4-Dioxane [LOINC component]
- 1,4-dioxane [Substance BNPC]
- Dioxane [ICD-11 Extension code]
- Dioxane (substance) [SNOMED CT concept]
- dioxane [SNOMED Notion]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients